Treatment of B cell malignancies with 13
✍
S. J. Denardo; G. L. Denardo; L. F. O'Grady; E. Hu; V. M. Sytsma; S. L. Mills; N
📂
Article
📅
1988
🏛
John Wiley and Sons
🌐
French
⚖ 689 KB
Lym-I is a murine IgG2, monoclonal antibody (MAb) that is B-cell specific but has greater avidity for malignant B cells when compared with normal B lymphocytes. It was originally produced by immunizing mice with nuclei of cultured cells from a patient with Burkitt's lymphoma. Ten patients with progr